Technical Success of the GoBack™ Crossing Catheter in Chronic Total Occlusion in Patients with Chronic Limb Threatening Ischemia.
Crossing catheter
Endovascular
Peripheral intervention
Reentry catheter
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
24
06
2021
accepted:
25
11
2021
pubmed:
24
3
2022
medline:
22
4
2022
entrez:
23
3
2022
Statut:
ppublish
Résumé
To assess the technical success of GoBack™ crossing catheter in chronic total occlusion. A retrospective review of chronic limb threatening ischemia (CLTI) patients treated for chronic total occlusions (CTO) with the application of the GoBack™ crossing catheter (Upstream Peripheral Technologies, Haifa, Israel) between May 2020 and January 2021 was performed. Sixteen GoBack catheters were applied in twelve limbs in 12 patients (ten men, average age 75.7 years). Treated limbs were classified as Rutherford Category 5 and 6 in ten patients and four in two patients. Average occlusion length was 287 mm (62-466). All occluded arteries were heavily calcified. Technical success was defined as successful application of the GoBack catheter for lesion crossing or luminal reentry. Successful application of the four French catheter was achieved in 11 of the 12 cases (92%) for reentry in external iliac (1), superficial femoral (2), popliteal (2) and posterior tibial (1) arteries in six out of six cases (100%) and lesion crossing in popliteal (4), peroneal (1) and posterior tibial arteries in five out of six cases (83%). The 2.9 Fr catheter was successfully applied once out of four (25%) in lesion crossing in the posterior tibial artery. The GoBack™ 4 Fr crossing catheter in revascularization of CLI patients with CTO could be valuable when manual crossing or reentry is unsuccessful and is applicable from any access site.
Identifiants
pubmed: 35318526
doi: 10.1007/s00270-021-03033-7
pii: 10.1007/s00270-021-03033-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
641-645Informations de copyright
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Références
Rabellino M, Zander T, Baldi S, et al. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment. Catheter Cardiovasc Interv. 2009;73(5):701–5.
doi: 10.1002/ccd.21971
Bisdas T, Borowski M, Stavroulakis K, Torsello G, Collaborators CR. C. R. I. T. I. S. C. H. Endovascular therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia: results of the interim analysis of the CRITISCH registry. JACC: Cardiovasc Interv. 2016;9(24):2557–65.
Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol. 1990;13(6):357–63.
doi: 10.1007/BF02578675
Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol. 2008;31(4):687–97.
doi: 10.1007/s00270-008-9331-7
Jacobs DL, Motaganahalli RL, Cox DE, et al. True lumen re-entry devices facilitate subintimal angioplasty and stenting of total chronic occlusions: initial report. J Vasc Surg. 2006;43(6):1291–6.
doi: 10.1016/j.jvs.2006.02.051
Kokkinidis DG, Katsaros I, Jonnalagadda AK, et al. Use, safety and effectiveness of subintimal angioplasty and re-entry devices for the treatment of femoropopliteal chronic total occlusions: a systematic review of 87 studies and 4,665 patients. Cardiovasc Revasc Med. 2020;21(1):34–45.
doi: 10.1016/j.carrev.2019.03.016
Shin SH, Baril D, Chaer R, et al. Limitations of the outback LTD re-entry device in femoropopliteal chronic total occlusions. J Vasc Surg. 2011;53(5):1260–4.
doi: 10.1016/j.jvs.2010.10.127
Gandini R, Pipitone V, Stefanini M, et al. The “Safari” technique to perform difficult subintimal infragenicular vessels. Cardiovasc Intervent Radiol. 2007;30(3):469–73.
doi: 10.1007/s00270-006-0099-3
Etezadi V, Benenati JF, Patel PJ, et al. The reentry catheter: a second chance for endoluminal reentry at difficult lower extremity subintimal arterial recanalizations. J Vasc Interv Radiol. 2010;21(5):730–4.
doi: 10.1016/j.jvir.2010.01.025
Baril DT, Chaer RA, Rhee RY, et al. Endovascular interventions for TASC II D femoropopliteal lesions. J Vasc Surg. 2010;51(6):1406–12.
doi: 10.1016/j.jvs.2010.01.062
Setacci C, Chisci E, De Donato G, et al. Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA. Eur J Vasc Endovasc Surg. 2009;38(1):76–87.
doi: 10.1016/j.ejvs.2009.03.020
Siablis D, Diamantopoulos A, Katsanos K, et al. Subintimal angioplasty of long chronic total femoropopliteal occlusions: long-term outcomes, predictors of angiographic restenosis, and role of stenting. Cardiovasc Intervent Radiol. 2012;35(3):483–90.
doi: 10.1007/s00270-011-0244-5